23985511000001100: Trastuzumab emtansine 160mg powder for solution for infusion vials (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual medicinal product\Trastuzumab emtansine 160mg powder for solution for infusion vials
\UK product\Virtual therapeutic moiety\Trastuzumab emtansine\Trastuzumab emtansine 160mg powder for solution for infusion vials

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab emtansine (medicinal product)\Trastuzumab emtansine\Trastuzumab emtansine 160mg powder for solution for infusion vials
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab emtansine (medicinal product)\Trastuzumab emtansine\Trastuzumab emtansine 160mg powder for solution for infusion vials
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab emtansine (medicinal product)\Trastuzumab emtansine\Trastuzumab emtansine 160mg powder for solution for infusion vials
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab emtansine (medicinal product)\Trastuzumab emtansine\Trastuzumab emtansine 160mg powder for solution for infusion vials
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab emtansine (medicinal product)\Trastuzumab emtansine\Trastuzumab emtansine 160mg powder for solution for infusion vials

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Mar 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

78536401000001117 Trastuzumab emtansine 160mg powder for solution for infusion vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

78536501000001118 Trastuzumab emtansine 160mg powder for solution for infusion vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Trastuzumab emtansine 160mg powder for solution for infusion vials	Is a	Trastuzumab emtansine	true	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	VMP prescribing status (attribute)	Caution - AMP level prescribing advised	true	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route	solutioninfusion.intravenous ontology form and route	true	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	Has NHS dm+d (dictionary of medicines and devices) dose form indicator	Discrete dose form indicator	true	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Intravenous route	true	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	Plays role	Antineoplastic therapeutic role	true	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	Is a	Trastuzumab emtansine	false	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	Has dispensed dose form	Powder for infusion solution	false	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	Has specific active ingredient	Trastuzumab emtansine	false	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	VMP prescribing status (attribute)	VMP valid as a prescribable product	false	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	Is a	Virtual medicinal product	true	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	Has active ingredient	Monoclonal antibody	false	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	Has specific active ingredient	Trastuzumab emtansine	true	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	Has manufactured dose form	Powder for infusion solution	false	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials	Has dispensed dose form	Powder for conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Kadcyla 160mg powder for concentrate for solution for infusion vials (Originalis B.V.)	Is a	True	Trastuzumab emtansine 160mg powder for solution for infusion vials	Inferred relationship	Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd)	Is a	True	Trastuzumab emtansine 160mg powder for solution for infusion vials	Inferred relationship	Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials 1 vial	Has VMP	True	Trastuzumab emtansine 160mg powder for solution for infusion vials	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
78536401000001117	Trastuzumab emtansine 160mg powder for solution for infusion vials (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
78536501000001118	Trastuzumab emtansine 160mg powder for solution for infusion vials	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module